Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors
Risks
Default risk
Data is available to registered users only
Volatility
Data is available to registered users only
Selling difficulty
Data is available to registered users only
Stress test
Data is available to registered users only
Country risks
Data is available to registered users only
Other risks
Data is available to registered users only
Sign up to access detailed risk analysis
About
MediPress Health-Limited Partnership is a venture capital firm and a life science research and development entity, primarily investing early-stage capital in startup companies. It targets businesses focused on innovation within the medical R&D sector. Its portfolio companies are actively involved in developing advanced treatments, including proton radiation therapy for cancer and non-surgical vaginal solutions for women experiencing various pelvic floor disorders. The partnership typically aims for strategic involvement by securing board positions within its investee companies. Established in 2021, MediPress Health-Limited Partnership is headquartered in Ramat Gan, Israel.